openPR Logo
Press release

Peptide Receptor Radionuclide Therapy (PRRT) Market Study Growth Factors, Types and Applications with Market Forecasts 2021 - 2028

07-13-2021 11:43 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Ameco Research

The worldwide Peptide Receptor Radionuclide Therapy (PRRT) report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner rather than later.

DOWNLOAD FREE SAMPLE STUDY PDF (INCLUDING FULL TOC, TABLE & FIGURES) @ https://www.amecoresearch.com/sample/269186

The Peptide Receptor Radionuclide Therapy (PRRT) market is finely sectioned by thinking about the most significant and responsive parts of the individual market. Furthermore, the fragments are all around examined for each topographical district including United States, European Union, China, Japan, India, Korea, and Southeast Asia. The significant nations are covered with nitty gritty data.

In particular, the effect of the COVID-19 pandemic that has disturbed the worldwide market as far as the production network, cash stream, and generally market financial matters is completely covered by remembering subjective and quantitative methodologies for the last report.
Aside from the division, the statistical surveying report includes set up essential devices (Value Chain Analysis, Supply Channel Analysis, Porter's five powers model, and others) that help people in simple arrangement and dissecting the general data in a more thorough and precise way.

CUSTOMIZED REQUIREMENTS? NEED ANY HELP? PLEASE EMAIL US AT@ sales@amecoresearch.com

The greater part of the top significant players are being shrouded in the examination report alongside their item contributions, income commitment, provincial presence, key turns of events, and business strength.

TABLE OF CONTENT:

1 Market Overview of Peptide Receptor Radionuclide Therapy (PRRT)
1.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Overview
1.1.1 Peptide Receptor Radionuclide Therapy (PRRT) Product Scope
1.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Status and Outlook
1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2016-2027)
1.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Region (2016-2021)
1.5 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
1.6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
1.6.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
1.6.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
1.6.4 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
1.6.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)

2 Peptide Receptor Radionuclide Therapy (PRRT) Market Overview by Type
2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2016-2021)
2.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2022-2027)
2.4 Gastroenteropancreatic Neuroendocrine Tumor
2.5 Foregut Neuroendocrine Tumor
2.6 Midgut Neuroendocrine Tumor
2.7 Hindgut Neuroendocrine Tumor

3 Peptide Receptor Radionuclide Therapy (PRRT) Market Overview by Application
3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Application (2016-2021)
3.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2022-2027)
3.4 Hospital Pharmacies
3.5 Retail Pharmacies
3.6 Online Pharmacies

4 Peptide Receptor Radionuclide Therapy (PRRT) Competition Analysis by Players
4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2020)
4.3 Date of Key Players Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
4.4 Global Top Players Peptide Receptor Radionuclide Therapy (PRRT) Headquarters and Area Served
4.5 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
4.6 Competitive Status
4.6.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Products, Services and Solutions
5.1.4 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$ Million) & (2016-2021)
5.1.5 Novartis Recent Developments
5.2 ITM Solucin
5.2.1 ITM Solucin Profile
5.2.2 ITM Solucin Main Business
5.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Products, Services and Solutions
5.2.4 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$ Million) & (2016-2021)
5.2.5 ITM Solucin Recent Developments
5.3 National Institutes of Health
5.5.1 National Institutes of Health Profile
5.3.2 National Institutes of Health Main Business
5.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Products, Services and Solutions
5.3.4 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$ Million) & (2016-2021)
5.3.5 Australasian Gastro-Intestinal Trials Group Recent Developments
5.4 Australasian Gastro-Intestinal Trials Group
5.4.1 Australasian Gastro-Intestinal Trials Group Profile
5.4.2 Australasian Gastro-Intestinal Trials Group Main Business
5.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Products, Services and Solutions
5.4.4 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$ Million) & (2016-2021)
5.4.5 Australasian Gastro-Intestinal Trials Group Recent Developments
...

6 North America
6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Peptide Receptor Radionuclide Therapy (PRRT) Market Dynamics
11.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Trends
11.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
11.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
11.4 Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

THE FINAL REPORT WILL COVER THE IMPACT ANALYSIS OF COVID-19, DOWNLOAD FULL STUDY REPORT@ https://www.amecoresearch.com/buy/269186

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom
Contact: (+44) 2032861546

ABOUT US

The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client's requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Receptor Radionuclide Therapy (PRRT) Market Study Growth Factors, Types and Applications with Market Forecasts 2021 - 2028 here

News-ID: 2327040 • Views:

More Releases from Ameco Research

HPAPI Market Spending on Track for USD 21.5 . Billion by 2032, Up 8.2CAGR
Introduction: High Potent Active Pharmaceutical Ingredients (HPAPIs) Market are compounds characterized by their high biological activity, necessitating stringent handling and manufacturing controls to ensure safety and efficacy. Recent trends in the pharmaceutical industry have spotlighted two significant aspects: the integration of artificial intelligence (AI) in HPAPI development and the implementation of advanced containment technologies. Request a free sample of our research report @ https://www.amecoresearch.com/sample/276609 How is Artificial Intelligence Transforming HPAPI Development? The pharmaceutical
Neurodiagnostics Market to Reach USD 13.9 Billion by 2030, Growing at a 7.9% CAGR | Insights and Forecast Till 2032
Neurodiagnostics Market to Reach USD 13.9 Billion by 2030, Growing at a 7.9% CAG …
Introduction: The global neurodiagnostics market is experiencing robust growth, fueled by the increasing prevalence of neurological disorders and technological advancements in diagnostic procedures. Valued at USD 7.1 billion in 2021, the market is projected to reach USD 13.9 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. This rise underscores the growing importance of neurodiagnostic tools, which are essential in diagnosing and monitoring conditions
Farm Equipment Rental Market to Reach USD 98.4 Billion by 2030: A Cost-Effective Solution for Modern Agriculture | Insights, Future Growth, and Opportunities
Farm Equipment Rental Market to Reach USD 98.4 Billion by 2030: A Cost-Effective …
Introduction The global farm equipment rental market is experiencing a notable growth trajectory. In 2021, the market was valued at USD 53.5 billion and is forecasted to nearly double, reaching USD 98.4 billion by 2030. This growth, at a steady CAGR of 7.1%, underscores the increasing demand for accessible, affordable agricultural machinery, which allows farmers to rent equipment like tractors, harvesters, sprayers, and specialized machinery for short or long-term use. As
Functional Apparel Market to Reach USD 691.2 Billion by 2030, Growing at a 7.2% CAGR - Key Trends, Opportunities, and Forecast Insights
Functional Apparel Market to Reach USD 691.2 Billion by 2030, Growing at a 7.2% …
Introduction: The global functional apparel market is experiencing exponential growth, driven by increasing consumer demand for multi-purpose clothing that combines comfort, style, and utility. The market, which was valued at USD 372.4 billion in 2021, is projected to reach USD 691.2 billion by 2030, with a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030. This significant growth highlights the increasing adoption of functional apparel across industries such as

All 4 Releases


More Releases for Peptide

Peptide Companies Reviewed Launches Independent Resource to Help Readers Compare …
The educational platform introduces a structured review methodology focused on transparency, documentation, testing standards, and fulfillment practices to help readers evaluate research peptide suppliers with greater confidence. Los Angeles, CA - August 17, 2026 - Peptide Companies Reviewed has launched an independent online resource designed to help readers compare research peptide suppliers using consistent editorial standards and publicly available information. The platform provides educational reviews and research guides that focus on
08-11-2026 | Health & Medicine
Getnews
Peptide Pod Launches a New Platform Bringing Peptide Podcasts and Research Toget …
The world's first dedicated peptide podcast platform brings trusted education, research, and leading voices together in one place. United States - August 10, 2026 - As interest in peptides continues to rise, finding trustworthy educational content has become increasingly difficult. New podcasts, research papers, and online discussions appear almost daily, leaving many people searching across multiple websites to stay informed. Peptide Pod [https://peptidepod.com/] is changing that by bringing peptide podcasts, research,
Automated Microwave Peptide Synthesizer Market Innovation: Accelerating High-Thr …
The global Automated Microwave Peptide Synthesizer Market is witnessing robust growth as pharmaceutical companies, biotechnology firms, and research organizations increasingly adopt automated peptide synthesis technologies to accelerate drug discovery and development. Automated microwave peptide synthesizers have transformed peptide manufacturing by significantly reducing synthesis time while improving reaction efficiency, reproducibility, and product quality. As peptide-based therapeutics continue gaining prominence across modern medicine, demand for advanced synthesis platforms is expanding rapidly. According to
Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity. United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity. The platform gives researchers access to more than 30 research compounds, each independently tested by third-party
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity. This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension